Related Experiment Video

Updated: Jul 6, 2026

Analysis of Hematopoietic Stem Progenitor Cell Metabolism
12:20

Analysis of Hematopoietic Stem Progenitor Cell Metabolism

Published on: November 9, 2019

Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell

Tiffany Holmes1, Tracey A O'Brien, Robert Knight

  • 1Sydney Cord and Marrow Transplant Facility, Sydney Children's Hospital, Randwick, New South Wales, Australia.

Stem Cells (Dayton, Ohio)
|March 8, 2008
PubMed

Insights

Inhibiting Glycogen synthase kinase-3beta (GSK-3beta) preserves hematopoietic stem cell (HSC) activity during ex vivo expansion. This method enhances HSC self-renewal and function, offering potential for improved transplantation therapies.

Area of Science:

  • Hematology
  • Stem Cell Biology
  • Molecular Medicine

Background:

  • Ex vivo expansion of cord blood hematopoietic stem cells (HSCs) often diminishes their in vivo activity.
  • Glycogen synthase kinase-3beta (GSK-3beta) regulates beta-catenin, a key factor in HSC self-renewal.
  • Understanding GSK-3beta's role is crucial for improving HSC expansion techniques.

Purpose of the Study:

  • To investigate the effect of GSK-3beta inhibition on the ex vivo expansion and function of cord blood HSCs.
  • To determine if GSK-3beta inhibition can enhance the preservation of stem cell activity and engraftment potential.
  • To explore the therapeutic potential of GSK-3beta modulators in HSC transplantation and leukemia treatment.

Main Methods:

  • Inhibition of GSK-3beta in CD34(+) cord blood cells.
  • Assessment of beta-catenin activation and its downstream targets (c-myc, HoxB4).
  • Evaluation of stem cell activity using long-term culture with bone marrow stroma and nonobese diabetic/SCID mouse models.

Main Results:

  • GSK-3beta inhibition activated beta-catenin, upregulating HSC self-renewal targets.
  • Delayed ex vivo expansion but enhanced preservation of stem cell activity and adherence to bone marrow stroma (via CXCR4).
  • Preservation of SCID repopulating cells and suppression of leukemic cell growth through apoptosis induction.

Conclusions:

  • GSK-3beta inhibition preserves HSC activity and function during ex vivo expansion by modulating the HSC-stroma interaction.
  • GSK-3beta inhibitors show promise for clinical applications in HSC transplantation and as novel anti-leukemic agents.
  • Targeting GSK-3beta may offer a strategy to selectively eliminate leukemic cells while protecting normal HSCs.

More Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...